Principal Investigator
Hadar Lev-Tov
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20250420
Clinical Trial Summary
A MULTICENTER, OPEN-LABEL STUDY TO ASSESS THE
PHARMACOKINETICS AND SAFETY OF BIMEKIZUMAB IN
PUBERTAL CHILDREN AND ADOLESCENTS WITH
MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other